Flag of the European Union EU Clinical Trials Register Help

Clinical trials for leti

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    49 result(s) found for: leti. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2013-001308-13 Sponsor Protocol Number: 301-PR-PRI-198 Start Date*: 2013-09-26
    Sponsor Name:LABORATORIOS LETI S.L.U
    Full Title: Biological standardization of Alternaria alternata allergen extract to determine the biological activity in histamine equivalent units (HEP).
    Medical condition: Allergy to Alternaria alternata
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2011-003634-14 Sponsor Protocol Number: 107-PR-PRI-185 Start Date*: 2012-02-17
    Sponsor Name:Laboratorios Leti, S.L.Unipersonal
    Full Title:
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021428 - Immune system disorders 10020419 House dust mite allergy LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2014-004732-19 Sponsor Protocol Number: 6043-PG-PSC-206 Start Date*: 2015-07-20
    Sponsor Name:LETI Pharma GmbH
    Full Title: A Randomised, Double-Blind, Parallel Group, Multicentre Study to Assess the Efficacy and Safety of Four Concentrations of Depigoid® Phleum versus Placebo in Patients with Allergic Rhinitis and/or R...
    Medical condition: Allergic Rhinitis and / or Rhinoconjunctivitis with or without Intermittent Asthma
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004853 10001728 Allergic rhinoconjunctivitis LLT
    18.0 100000004855 10001705 Allergic asthma LLT
    18.0 100000004855 10001723 Allergic rhinitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) PL (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2012-001939-31 Sponsor Protocol Number: 101-PR-PRI-196 Start Date*: 2013-02-13
    Sponsor Name:LABORATORIOS LETI S.L.U
    Full Title: Biological standardization of Dermatophagoides pteronyssinus allergen extract to determine the biological activity in histamine equivalent units (HEP).
    Medical condition: Allergy to Dermatophagoides pteronyssinus
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004870 10020419 House dust mite allergy LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2006-003067-31 Sponsor Protocol Number: 600-PG-PSC-156 Start Date*: 2006-09-25
    Sponsor Name:LETI Pharma GmbH
    Full Title: A randomized, double blinded, placebo controlled multicenter study for the efficacy and safety of Depigoid® tree pollen
    Medical condition: Rhinitis and/or rhinoconjunctivitis with or without allergic asthma caused by clinical relevant sensitization against tree pollen.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10039083 Rhinitis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: LT (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2012-001931-30 Sponsor Protocol Number: 206-PG-PRI-190 Start Date*: 2012-10-18
    Sponsor Name:Laboratorios LETI, S.L.U
    Full Title: Ensayo Clínico multicéntrico, abierto, para la comparación de la potencia biológica entre los extractos alergénicos nativo, despigmentado y despigmentado-polimerizado de epitelio de gato.
    Medical condition: Alergia frente al epitelio de gato
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021428 - Immune system disorders 10001731 Allergic to cats LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2013-001310-15 Sponsor Protocol Number: 6058-PR-PRI-200 Start Date*: 2013-10-28
    Sponsor Name:LABORATORIOS LETI, S.L.U
    Full Title: Biological standardization of Artemisia vulgaris allergen extract to determine the biological activity in histamine equivalent units (HEP).
    Medical condition: Allergy to Artermisia vulgaris
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004870 10036019 Pollen allergy LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-001937-15 Sponsor Protocol Number: 6062-PR-PRI-195 Start Date*: 2012-09-28
    Sponsor Name:Laboratorios Leti, S.L.Unipersonal
    Full Title: Biological standardization of Chenopodium album allergen extract to determine the biological activity in HEP units.
    Medical condition: Allergy to Chenopodium album
    Disease: Version SOC Term Classification Code Term Level
    15.0 10021428 - Immune system disorders 10036019 Pollen allergy LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2006-003065-14 Sponsor Protocol Number: 6078-PG-PSC-141 Start Date*: 2007-02-26
    Sponsor Name:LETI Pharma GmbH
    Full Title: Investigation of a preseasonal rush treatment scheme with Depigoid® Grass Mix as an add-on therapy in patients with allergic rhinitis and/or rhinoconjunctivitis sensitized to grass pollen
    Medical condition: Intermittent rhinitis and/or rhinoconjunctivitis with or without asthma bronchial caused by clinical relevant sensitisation against grass pollen.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10039083 Rhinitis LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-005269-20 Sponsor Protocol Number: 6078-PG-PSC-158 Start Date*: 2007-01-15
    Sponsor Name:LETI Pharma GmbH
    Full Title: Randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy of Depigoid® Grass Mix as a rush immunotherapy in patients with allergic rhinitis using an environmental ...
    Medical condition: Allergic rhinitis and/or rhinoconjunctivitis with or without mild intermittent asthma caused by clinical relevant sensitization against grass pollen.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10039083 Rhinitis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-000602-23 Sponsor Protocol Number: 101-PG-COM-144 Start Date*: 2007-09-17
    Sponsor Name:Laboratorios LETI S.L.
    Full Title: A randomized double blind, placebo controlled study to evaluate the efficacy and security of immunotherapy with a depigmented and polymerized allergen extract of Dermatophagoides pteronyssinus in p...
    Medical condition: Mild to moderate asthma caused by sensitization againts dust mite Dermatophagoides Pteronyssinus.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10001705 Allergic asthma LLT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: PT (Not Authorised)
    Trial results: (No results available)
    EudraCT Number: 2011-000870-79 Sponsor Protocol Number: 101-PG-PSC-186 Start Date*: 2012-02-17
    Sponsor Name:Laboratorios LETI, S.L.U.
    Full Title: Prospective study to evaluate the safety of a 4-month treatment with Depigoid® Dermatophagoides pteronyssinus or 50% Dermatophagoides pteronyssinus / 50% Dermatophagoides farinae (500 DPP/ml) in pa...
    Medical condition: Allergic rhinitis or rhinoconjunctivitis with or without mild persistent or intermittent asthma, to Dermatophagoides pteronyssinus or Dermatophagoides pteronyssinus and Dermatophagoides farinae.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10021428 - Immune system disorders 10020419 House dust mite allergy LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2005-001880-68 Sponsor Protocol Number: 1001-PR-PRI-133 Start Date*: 2005-09-23
    Sponsor Name:LETI Pharma GmbH
    Full Title: Standardization of Latex allergenic extract. Determination of biological activity in HEP units
    Medical condition: The objective of the study is to know the biologic activity of the Latex reference extract (IHRP) in HEP units. The HEP value will be the reference of every other diagnostic or treatment preparations.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2006-003408-20 Sponsor Protocol Number: 6080-PR-PRI-146 Start Date*: 2007-07-16
    Sponsor Name:Laboratorios Leti, S.L.unipersonal
    Full Title: Extracto alergénico de Salsola oppositifolia Determinación de la potencia alergénica in vivo en unidades equivalentes de histamina (HEP)
    Medical condition: Alergia frente a la hierba salsola oppositifolia
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2013-004920-12 Sponsor Protocol Number: PRO-2013 Start Date*: 2014-02-12
    Sponsor Name:LETI Pharma GmbH
    Full Title: Non-interventional Study in Allergic Patients Suffering from Grass Pollen Induced Rhinitis/Rhinoconjunctivitis with or without Asthma. Retrospective Assessment of the Efficacy of a Perennial Speci...
    Medical condition: Allergic rhinitis/rhinoconjunctivitis with or without concomitant asthma due to grass pollen allergy
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004853 10001728 Allergic rhinoconjunctivitis LLT
    14.1 100000004855 10001705 Allergic asthma LLT
    14.1 100000004855 10001723 Allergic rhinitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: CZ (Completed)
    Trial results: View results
    EudraCT Number: 2010-023948-33 Sponsor Protocol Number: 6038-PR-PRI-181 Start Date*: 2011-08-16
    Sponsor Name:LABORATORIOS LETI, S.L. UNIPERSONAL
    Full Title:
    Medical condition:
    Disease: Version SOC Term Classification Code Term Level
    14.0 10021428 - Immune system disorders 10036019 Pollen allergy LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2011-002096-42 Sponsor Protocol Number: 6057-PR-PRI-188 Start Date*: 2012-09-18
    Sponsor Name:LETI Pharma GmbH
    Full Title: Biological Standardization of Ambrosia elatior Allergen Extract Determination of the Biological Activity in HEP units. An Open Monocenter Study.
    Medical condition: Allergy to Ambrosia elatior (ragweed)
    Disease: Version SOC Term Classification Code Term Level
    14.1 10022891 - Investigations 10036664 Prick test LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2012-000414-11 Sponsor Protocol Number: 603-PG-PSC-191 Start Date*: 2012-08-31
    Sponsor Name:LETI Pharma GmbH
    Full Title: Multicenter, placebo-controlled, long-term study of Depigoid Birch 5000 in adults and adolescents with allergic rhinitis and/or rhinoconjunctivitis with or without intermittent asthma
    Medical condition: Seasonal allergic rhinitis and/or rhinoconjunctivitis with or without intermittent asthma due to birch pollen allergy
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004870 10066093 Birch pollen allergy LLT
    Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) LT (Completed) CZ (Completed) FI (Completed) PL (Completed) LV (Completed)
    Trial results: View results
    EudraCT Number: 2012-001699-12 Sponsor Protocol Number: 6078-PG-PSC-193 Start Date*: 2012-10-18
    Sponsor Name:Laboratorios LETI, S.L.U
    Full Title: Prospective, open uncontrolled study to evaluate the safety of Depigoid with two pollen combinations ( Grasses/Olea and Grasses/ Parietaria) 2000 DPP/ml in patients with allergic rhinitis or rhinoc...
    Medical condition: Allergic rhinitis or rhinojunctivitis, with or without seasonal asthma to more than one of the following pollens: Grasses, Olea europaea and Parietaria judaica.
    Disease: Version SOC Term Classification Code Term Level
    15.0 10021428 - Immune system disorders 10036019 Pollen allergy LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2012-001938-34 Sponsor Protocol Number: 6022-PR-PRI-194 Start Date*: 2012-11-06
    Sponsor Name:Laboratorios Leti, S.L.Unipersonal
    Full Title: Biological standardization of Platanus acerifolia allergen extract to determine the biological activity in HEP units.
    Medical condition: Allergy to Platanus acerifolia
    Disease: Version SOC Term Classification Code Term Level
    15.0 10021428 - Immune system disorders 10036019 Pollen allergy LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 08 07:45:24 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA